Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q2 2023 Earnings Call Transcript

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q2 2023 Earnings Call Transcript August 9, 2023

Jazz Pharmaceuticals plc beats earnings expectations. Reported EPS is $4.51, expectations were $4.46.

Operator: Good afternoon and thank you for attending the Jazz Pharmaceuticals Second Quarter 2023 Financial Results Call. My name is Elissa, and I will be your moderator for today’s call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at...